Too many women are dying from cervix cancer: Problems and solutions von Gaffney, David K., Hashibe, Mia, Kepka, Deanna, Maurer, Kathryn A., Werner, Theresa L.

Volltext

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial von Mirza, Mansoor Raza, MD, Åvall Lundqvist, Elisabeth, PhD, Birrer, Michael J, Prof, dePont Christensen, Rene, PhD, Nyvang, Gitte-Bettina, MD, Malander, Susanne, PhD, Anttila, Maarit, PhD, Werner, Theresa L, MD, Lund, Bente, MD, Lindahl, Gabriel, MD, Hietanen, Sakari, PhD, Peen, Ulla, MD, Dimoula, Maria, MD, Roed, Henrik, DMSci, Ør Knudsen, Anja, MD, Staff, Synnöve, PhD, Krog Vistisen, Anders, MD, Bjørge, Line, Prof, Mäenpää, Johanna U, Prof

Volltext

Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy von Francis, Samual R., Ager, Bryan J., Do, Olivia A., Huang, Yu-Huei Jessica, Soisson, Andrew P., Dodson, Mark K., Werner, Theresa L., Sause, William T., Grant, Jonathan D., Gaffney, David K.

Volltext

Combating subclonal evolution of resistant cancer phenotypes von Brady, Samuel W., McQuerry, Jasmine A., Qiao, Yi, Piccolo, Stephen R., Shrestha, Gajendra, Jenkins, David F., Layer, Ryan M., Pedersen, Brent S., Miller, Ryan H., Esch, Amanda, Selitsky, Sara R., Parker, Joel S., Anderson, Layla A., Dalley, Brian K., Factor, Rachel E., Reddy, Chakravarthy B., Boltax, Jonathan P., Li, Dean Y., Moos, Philip J., Gray, Joe W., Heiser, Laura M., Buys, Saundra S., Cohen, Adam L., Johnson, W. Evan, Quinlan, Aaron R., Marth, Gabor, Werner, Theresa L., Bild, Andrea H.

Volltext

A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker von Kelley, Kristen C, Grossman, Kenneth F, Brittain-Blankenship, Mary, Thorne, Kelli M, Akerley, Wallace L, Terrazas, Moises C, Kosak, Ken M, Boucher, Kenneth M, Buys, Saundra S, McGregor, Kimberly A, Werner, Theresa L, Agarwal, Neeraj, Weis, John R, Sharma, Sunil, Ward, John H, Kennedy, Thomas P, Sborov, Douglas W, Shami, Paul J

Volltext

Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer von Lheureux, Stephanie, Matei, Daniela E, Konstantinopoulos, Panagiotis A, Wang, Ben X, Gadalla, Ramy, Block, Matthew S, Jewell, Andrea, Gaillard, Stephanie L, McHale, Michael, McCourt, Carolyn, Temkin, Sarah, Girda, Eugenia, Backes, Floor J, Werner, Theresa L, Duska, Linda, Kehoe, Siobhan, Colombo, Ilaria, Wang, Lisa, Li, Xuan, Wildman, Rachel, Soleimani, Shirin, Lien, Scott, Wright, John, Pugh, Trevor, Ohashi, Pamela S, Brooks, David G, Fleming, Gini F

Volltext

Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer von Sama, Shashank, Rosqvist, Sterling, Savage, Talicia, Lomo, Lesley, Sibbald, Kiera, Straubhar, Alli, Werner, Theresa L.

Volltext

Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site von Albright, Frederick, Teerlink, Craig, Werner, Theresa L, Cannon-Albright, Lisa A

Volltext

Prognostic factors for rural endometrial cancer patients in a population-based cohort von Blackburn, Brenna E, Soisson, Sean, Rowe, Kerry, Snyder, John, Fraser, Alison, Deshmukh, Vikrant, Newman, Michael, Smith, Ken, Herget, Kimberly, Kirchhoff, Anne C, Kepka, Deanna, Werner, Theresa L, Gaffney, David, Mooney, Kathi, Hashibe, Mia

Volltext

Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors von Kang, Yoon-Koo, Ryu, Min-Hee, Hong, Yong Sang, Choi, Chang-Min, Kim, Tae Won, Ryoo, Baek-Yeol, Kim, Jeong Eun, Weis, John R, Kingsford, Rachel, Park, Cheol Hee, Jang, Seong, McGinn, Arlo, Werner, Theresa L, Sharma, Sunil

Volltext

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer von Coleman, Robert L, Fleming, Gini F, Brady, Mark F, Swisher, Elizabeth M, Steffensen, Karina D, Friedlander, Michael, Okamoto, Aikou, Moore, Kathleen N, Efrat Ben-Baruch, Noa, Werner, Theresa L, Cloven, Noelle G, Oaknin, Ana, DiSilvestro, Paul A, Morgan, Mark A, Nam, Joo-Hyun, Leath, Charles A, Nicum, Shibani, Hagemann, Andrea R, Littell, Ramey D, Cella, David, Baron-Hay, Sally, Garcia-Donas, Jesus, Mizuno, Mika, Bell-McGuinn, Katherine, Sullivan, Danielle M, Bach, Bruce A, Bhattacharya, Sudipta, Ratajczak, Christine K, Ansell, Peter J, Dinh, Minh H, Aghajanian, Carol, Bookman, Michael A

Volltext

Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes von Brady, Samuel W., McQuerry, Jasmine A., Qiao, Yi, Piccolo, Stephen R., Shrestha, Gajendra, Jenkins, David F., Layer, Ryan M., Pedersen, Brent S., Miller, Ryan H., Esch, Amanda, Selitsky, Sara R., Parker, Joel S., Anderson, Layla A., Dalley, Brian K., Factor, Rachel E., Reddy, Chakravarthy B., Boltax, Jonathan P., Li, Dean Y., Moos, Philip J., Gray, Joe W., Heiser, Laura M., Buys, Saundra S., Cohen, Adam L., Johnson, W. Evan, Quinlan, Aaron R., Marth, Gabor, Werner, Theresa L., Bild, Andrea H.

Volltext

LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? von Harris, Katherine L., Maurer, Kathryn A., Jarboe, Elke, Werner, Theresa L., Gaffney, David

Volltext

Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study von Soisson, Sean, Ganz, Patricia A, Gaffney, David, Rowe, Kerry, Snyder, John, Wan, Yuan, Deshmukh, Vikrant, Newman, Mike, Fraser, Alison, Smith, Ken, Herget, Kimberly, Hanson, Heidi A, Wu, Yelena P, Stanford, Joseph, Al-Sarray, Ali, Werner, Theresa L, Setiawan, Veronica W, Hashibe, Mia

Volltext

First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies von Munster, Pamela, Aggarwal, Rahul, Hong, David, Schellens, Jan H M, van der Noll, Ruud, Specht, Jennifer, Witteveen, Petronella O, Werner, Theresa L, Dees, E Claire, Bergsland, Emily, Agarwal, Neeraj, Kleha, Joseph F, Durante, Michael, Adams, Laurel, Smith, Deborah A, Lampkin, Thomas A, Morris, Shannon R, Kurzrock, Razelle

Volltext

Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer von Pant, Shubham, Cho, Byoung Chul, Kyriakopoulos, Christos E, Spira, Alexander, Tannir, Nizar, Werner, Theresa L, Yan, Xiaohong, Neuteboom, Saskia, Chao, Richard, Goel, Sanjay

Volltext

Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model von Taurin, Sebastien, Yang, Chieh-Hsiang, Reyes, Maria, Cho, Sungpil, Coombs, Demetrius M, Jarboe, Elke A, Werner, Theresa L, Peterson, C Matthew, Janát-Amsbury, Margit M

Volltext

First‐in‐human, phase I study of PF‐06647263, an anti‐EFNA4 calicheamicin antibody–drug conjugate, in patients with advanced solid tumors von Garrido‐Laguna, Ignacio, Krop, Ian, Burris, Howard A., Hamilton, Erika, Braiteh, Fadi, Weise, Amy M., Abu‐Khalaf, Maysa, Werner, Theresa L., Pirie‐Shepherd, Steven, Zopf, Christopher J., Lakshminarayanan, Mani, Holland, Jaymes S., Baffa, Raffaele, Hong, David S.

Volltext

Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival von Boothe, Dustin, Orton, Andrew, Odei, Bismarck, Stoddard, Gregory, Suneja, Gita, Poppe, Matthew M, Werner, Theresa L, Gaffney, David K

Volltext

Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival von Odei, Bismarck, Boothe, Dustin, Suneja, Gita, Werner, Theresa L, Gaffney, David K

Volltext